Kiniksa Pharmaceuticals Short Interest Ratio and Short Volume

Short interest is the volume of Kiniksa Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 4,230,000 shares of KNSA short.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Kiniksa Pharmaceuticals currently has a short interest ratio of 8.0.

Kiniksa Pharmaceuticals saw a increase in short interest in April. As of April 15th, there was short interest totaling 4,230,000 shares, an increase of 11.9% from the previous total of 3,780,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Kiniksa Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Kiniksa Pharmaceuticals: Hutchison China MediTech Limited (0.00%), Arena Pharmaceuticals, Inc. (0.00%), Alkermes plc (0.00%), Apellis Pharmaceuticals, Inc. (0.00%), ACADIA Pharmaceuticals Inc. (0.00%), Nektar Therapeutics (0.00%), Turning Point Therapeutics, Inc. (0.00%), Agios Pharmaceuticals, Inc. (0.00%), Karuna Therapeutics, Inc. (8.24%), and Emergent BioSolutions Inc. (7.21%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.85 billion), Aon plc ($5.61 billion), Charter Communications, Inc. ($5.44 billion), Snap Inc. ($3.49 billion), Airbnb, Inc. ($3.35 billion), Peloton Interactive, Inc. ($2.53 billion), ViacomCBS Inc. ($2.48 billion), Expedia Group, Inc. ($2.39 billion), The Kroger Co. ($2.26 billion), and Nuance Communications, Inc. ($2.18 billion). View all of the most shorted stocks.

Short selling KNSA is an investing strategy that aims to generate trading profit from Kiniksa Pharmaceuticals as its price is falling. Kiniksa Pharmaceuticals' stock is trading up $0.30 today. To short Kiniksa Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Kiniksa Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Kiniksa Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KNSA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KNSA, twice per month. The most recent reporting period available is April, 15 2021.